Abstract:AlphaFold2 (AF2) and RoseTTaFold (RF) have revolutionized structural biology, serving as highly reliable and effective methods for predicting protein structures. This article explores their impact and limitations, focusing on their integration into experimental pipelines and their application in diverse protein classes, including membrane proteins, intrinsically disordered proteins (IDPs), and oligomers. In experimental pipelines, AF2 models help X-ray crystallography in resolving the phase problem, while complementarity with mass spectrometry and NMR data enhances structure determination and protein flexibility prediction. Predicting the structure of membrane proteins remains challenging for both AF2 and RF due to difficulties in capturing conformational ensembles and interactions with the membrane. Improvements in incorporating membrane-specific features and predicting the structural effect of mutations are crucial. For intrinsically disordered proteins, AF2's confidence score (pLDDT) serves as a competitive disorder predictor, but integrative approaches including molecular dynamics (MD) simulations or hydrophobic cluster analyses are advocated for accurate dynamics representation. AF2 and RF show promising results for oligomeric models, outperforming traditional docking methods, with AlphaFold-Multimer showing improved performance. However, some caveats remain in particular for membrane proteins. Real-life examples demonstrate AF2's predictive capabilities in unknown protein structures, but models should be evaluated for their agreement with experimental data. Furthermore, AF2 models can be used complementarily with MD simulations. In this Perspective, we propose a "wish list" for improving deep-learning-based protein folding prediction models, including using experimental data as constraints and modifying models with binding partners or post-translational modifications. Additionally, a meta-tool for ranking and suggesting composite models is suggested, driving future advancements in this rapidly evolving field.

Revealing missing protein-ligand interactions using AlphaFold predictions

From interaction networks to interfaces, scanning intrinsically disordered regions using AlphaFold2

Systematic discovery of protein interaction interfaces using AlphaFold and experimental validation

AlphaFold2 knows some protein folding principles

AlphaFold illuminates half of the dark human proteins

Conservation of Hot Spots and Ligand Binding Sites in Protein Models by AlphaFold2

AlphaFold 2: Why It Works and Its Implications for Understanding the Relationships of Protein Sequence, Structure, and Function

Improved prediction of protein-protein interactions using AlphaFold2

How accurately can one predict drug binding modes using AlphaFold models?

Dissecting AlphaFolds Capabilities with Limited Sequence Information

AlphaFold2: A Role for Disordered Protein/Region Prediction?

Interpretable Atomistic Prediction and Functional Analysis of Conformational Ensembles and Allosteric States in Protein Kinases Using AlphaFold2 Adaptation with Randomized Sequence Scanning and Local Frustration Profiling

AlphaFold-Metainference: Prediction of Structural Ensembles of Disordered Proteins

AlphaFold predictions of fold-switched conformations are driven by structure memorization

Benchmarking AlphaFold for protein complex modeling reveals accuracy determinants

Unmasking AlphaFold to integrate experiments and predictions in multimeric complexes

AlphaFold2 structures guide prospective ligand discovery

High-throughput discovery of inhibitory protein fragments with AlphaFold

A Perspective on the Prospective Use of AI in Protein Structure Prediction

AlphaFold and the amyloid landscape

Using AlphaFold Multimer to discover interkingdom protein-protein interactions